Flaxseed and Amitiza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flaxseed (flaxseed) and Amitiza (lubiprostone). Common drug interactions include infection among females and infective pulmonary exacerbation of cystic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Flaxseed and Amitiza. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Flaxseed?

Flaxseed has active ingredients of flaxseed. It is often used in high blood cholesterol. eHealthMe is studying from 7,137 Flaxseed users. Check the latest studies of Flaxseed.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

55 people who take Flaxseed and Amitiza together, and have interactions are studied.

Flaxseed and Amitiza drug interactions.

What are the common drug interactions of Flaxseed and Amitiza, by gender? *:

female:

  1. Infection
  2. Initial insomnia (feeling of inadequate or poor-quality sleep)
  3. Injection site pruritus (severe itching at injection site)
  4. Injection site urticaria (rash of round, red welts on the skin at injection site)
  5. Nausea (feeling of having an urge to vomit)
  6. Road traffic accident
  7. Weight increased
  8. Anaemia (lack of blood)
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Fall

male:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Nail infection
  3. Sinusitis (inflammation of sinus)

What are the common drug interactions of Flaxseed and Amitiza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

20-29:

  1. Infection
  2. Injection site pruritus (severe itching at injection site)
  3. Injection site urticaria (rash of round, red welts on the skin at injection site)
  4. Sinusitis (inflammation of sinus)
  5. Headache (pain in head)
  6. Injection site bruising
  7. Nausea (feeling of having an urge to vomit)
  8. Oral candidiasis (fungal infection of mouth)
  9. Vomiting
  10. Withdrawal bleed (bleeding occurs between periods)

30-39:

n/a

40-49:

  1. Bipolar disorder (mood disorder)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Hypoxia (low oxygen in tissues)
  4. Road traffic accident
  5. Hepatic rupture (rapture of common benign tumour of liver)
  6. Pelvic floor dyssynergia (problem with the way certain nerves and muscles function in the pelvic floor)
  7. Liver injury

50-59:

  1. Fatigue (feeling of tiredness)
  2. Actinic keratosis (skin disease due to sun exposure)
  3. Agitation (state of anxiety or nervous excitement)
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Bowen's disease (early stage of skin cancer)
  6. Drug ineffective
  7. Insomnia (sleeplessness)
  8. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  9. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

60+:

  1. Dizziness
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Memory impairment
  4. Vision blurred
  5. Activities of daily living impaired
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Device occlusion
  9. Diarrhoea
  10. Diplopia (double vision)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 27 people, 49.09%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 17 people, 30.91%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 10.91%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.09%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 9.09%
  6. Immune System Disorder: 4 people, 7.27%
  7. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 5.45%
  8. High Blood Pressure: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Flaxseed and Amitiza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flaxseed and Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flaxseed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flaxseed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitiza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on flaxseed and lubiprostone (the active ingredients of Flaxseed and Amitiza, respectively), and Flaxseed and Amitiza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: